Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

ClinicalTrials.gov ID: NCT03521934

Public ClinicalTrials.gov record NCT03521934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 7:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of Sotagliflozin on Clinical Outcomes in Hemodynamically Stable Patients With Type 2 Diabetes POST Worsening Heart Failure

Study identification

NCT ID
NCT03521934
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lexicon Pharmaceuticals
Industry
Enrollment
1,222 participants

Conditions and interventions

Interventions

  • Sotagliflozin Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 14, 2018
Primary completion
Jun 4, 2020
Completion
Jun 4, 2020
Last update posted
Oct 27, 2022

2018 – 2020

United States locations

U.S. sites
94
U.S. states
33
U.S. cities
86
Facility City State ZIP Site status
Investigational Site Number 8400128 Alexander City Alabama 35010
Investigational Site Number 8400109 Cottonwood Arizona 86326
Investigational Site Number 8400032 Little Rock Arkansas 72205
Investigational Site Number 8400080 Little Rock Arkansas 72205
Investigational Site Number 8400075 Bakersfield California 93309
Investigational Site Number 8400069 Fresno California 93701
Investigational Site Number 8400008 Los Angeles California 90024
Investigational Site Number 8400063 Los Angeles California 90073
Investigational Site Number 8400127 National City California 91950
Investigational Site Number 8400007 Redondo Beach California 90277
Investigational Site Number 8400036 Stockton California 95204
Investigational Site Number 8400033 Sylmar California 91342
Investigational Site Number 8400049 Torrance California 90502
Investigational Site Number 8400028 Walnut Creek California 94598
Investigational Site Number 8400029 Bridgeport Connecticut 06606
Investigational Site Number 8400037 New Haven Connecticut 06519
Investigational Site Number 8400046 DeLand Florida 32720
Investigational Site Number 8400009 Gainesville Florida 32608
Investigational Site Number 8400079 Homestead Florida 33033
Investigational Site Number 8400031 Jacksonville Florida 32207
Investigational Site Number 8400022 Jacksonville Florida 32216
Investigational Site Number 8400098 Lake Mary Florida 32746
Investigational Site Number 8400058 Miami Beach Florida 33140
Investigational Site Number 8400105 Orlando Florida 32806
Investigational Site Number 8400082 Pensacola Florida 32504
Investigational Site Number 8400057 Port Charlotte Florida 33952
Investigational Site Number 8400006 Sarasota Florida 34239
Investigational Site Number 8400035 Tampa Florida 33609
Investigational Site Number 8400042 Tampa Florida 33612
Investigational Site Number 8400004 Wellington Florida 33449
Investigational Site Number 8400073 Atlanta Georgia 30322-1020
Investigational Site Number 8400118 Tucker Georgia 30084
Investigational Site Number 8400067 Arlington Heights Illinois 60005
Investigational Site Number 8400043 Chicago Illinois 60637
Investigational Site Number 8400072 Elk Grove Village Illinois 60007
Investigational Site Number 8400055 Indianapolis Indiana 46060
Investigational Site Number 8400020 Muncie Indiana 47303-3400
Investigational Site Number 8400122 Richmond Indiana 47374
Investigational Site Number 8400091 Waterloo Iowa 50702
Investigational Site Number 8400030 Covington Louisiana 70433
Investigational Site Number 8400065 Annapolis Maryland 21401
Investigational Site Number 8400012 Boston Massachusetts 02118
Investigational Site Number 8400001 Cambridge Massachusetts 02135
Investigational Site Number 8400077 Detroit Michigan 48202
Investigational Site Number 8400062 Kalamazoo Michigan 49009
Investigational Site Number 8400017 Kalamazoo Michigan 49048
Investigational Site Number 8400107 Duluth Minnesota 55805
Investigational Site Number 8400056 Jackson Mississippi 39216
Investigational Site Number 8400019 Columbia Missouri 65201
Investigational Site Number 8400103 Lee's Summit Missouri 64064
Investigational Site Number 8400132 Grand Island Nebraska 68803
Investigational Site Number 8400130 Lincoln Nebraska 68506
Investigational Site Number 8400083 Omaha Nebraska 68124
Investigational Site Number 8400071 Omaha Nebraska 68198
Investigational Site Number 8400015 Ridgewood New Jersey 07450-2736
Investigational Site Number 8400050 Voorhees Township New Jersey 08043
Investigational Site Number 8400131 Albuquerque New Mexico 87131
Investigational Site Number 8400051 Brooklyn New York 11203
Investigational Site Number 8400111 Buffalo New York 14215
Investigational Site Number 8400097 The Bronx New York 10457
Investigational Site Number 8400061 The Bronx New York 10468-3904
Investigational Site Number 8400045 Greensboro North Carolina 27401
Investigational Site Number 8400085 Raleigh North Carolina 27610
Investigational Site Number 8400078 Winston-Salem North Carolina 27157
Investigational Site Number 8400087 Cincinnati Ohio 45220
Investigational Site Number 8400047 Cincinnati Ohio 45267
Investigational Site Number 8400095 Maumee Ohio 43537
Investigational Site Number 8400099 Toledo Ohio 43699
Investigational Site Number 8400121 Zanesville Ohio 43701
Investigational Site Number 8400054 Arlington Oregon 19001
Investigational Site Number 8400134 Doylestown Pennsylvania 18901
Investigational Site Number 8400044 Natrona Heights Pennsylvania 15065
Investigational Site Number 8400115 Philadelphia Pennsylvania 19104
Investigational Site Number 8400039 Sayre Pennsylvania 18840
Investigational Site Number 8400114 Providence Rhode Island 02903
Investigational Site Number 8400100 Warwick Rhode Island 02886
Investigational Site Number 8400059 Charleston South Carolina 29425
Investigational Site Number 8400092 Columbia South Carolina 29203
Investigational Site Number 8400104 Greenville South Carolina 29605
Investigational Site Number 8400040 Rapid City South Dakota 57701
Investigational Site Number 8400088 Greenville Tennessee 30000
Investigational Site Number 8400089 Memphis Tennessee 38104
Investigational Site Number 8400053 Nashville Tennessee 37212
Investigational Site Number 8400041 Brownsville Texas 78521
Investigational Site Number 8400074 Dallas Texas 75226
Investigational Site Number 8400016 Houston Texas 77030
Investigational Site Number 8400123 McKinney Texas 75071
Investigational Site Number 8400101 New Braunfels Texas 78130
Investigational Site Number 8400066 Victoria Texas 77901
Investigational Site Number 8400093 Manassas Virginia 20109
Investigational Site Number 8400003 Richmond Virginia 23249-0001
Investigational Site Number 8400126 Clarksburg West Virginia 26301
Investigational Site Number 8400038 Morgantown West Virginia 26506
Investigational Site Number 8400048 Manitowoc Wisconsin 54220

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 372 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03521934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 27, 2022 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03521934 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →